IBERE PHARMACEUTICALS SEC EDGAR Filings (CIK 0001835205)

SEC EDGAR filings, ownership reports, and insider transactions for IBERE PHARMACEUTICALS.

Industry
Blank Checks (Office Of Real Estate & Construction)
Business address
2005 Market Street, Suite 2030, Philadelphia, PA, 19103
State of incorporation
Cayman Islands
Fiscal year end
31 December
⭐ Add to watchlist ⭐
IBERE PHARMACEUTICALS has filed 51 SEC EDGAR filings since 07 Dec 2020

Latest Filings

Recent SEC filings for IBERE PHARMACEUTICALS including 15-12G, 25-NSE, 8-K and more.

Form type Document Filing Description Filing date Reporting date File number(s)
15-12G Open 15-12G document View SEC filing for 15-12G 15-12G 13 Mar 2023 001-40119
25-NSE Open 25-NSE document View SEC filing for 25-NSE 02 Mar 2023 001-40119
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 15 Feb 2023 15 Feb 2023 001-40119
SC 13G Open SC 13G document View SEC filing for SC 13G 14 Feb 2023 005-92346
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 14 Feb 2023 005-92346
SC 13G Open SC 13G document View SEC filing for SC 13G IBER 13G 08 Feb 2023 005-92346
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 08 Feb 2023 005-92346
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 02 Feb 2023 005-92346
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 Nov 2022 30 Sep 2022 001-40119
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Aug 2022 30 Jun 2022 001-40119
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 16 May 2022 31 Mar 2022 001-40119
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 31 Mar 2022 31 Dec 2021 001-40119
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A IBERE PHARMACEUTICALS 14 Feb 2022 005-92346
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 08 Feb 2022 005-92346
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 14 Jan 2022 005-92346
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 12 Nov 2021 30 Sep 2021 001-40119
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 27 Sep 2021 005-92346
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 16 Aug 2021 30 Jun 2021 001-40119
10-Q/A Open 10-Q/A document | Open XBRL data View SEC filing for 10-Q/A 10-Q/A 16 Aug 2021 31 Mar 2021 001-40119
8-K/A Open 8-K/A document View SEC filing for 8-K/A FORM 8-K/A 16 Aug 2021 02 Mar 2021 001-40119
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 13 Aug 2021 10 Aug 2021 001-40119
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 04 Aug 2021 29 Jul 2021 001-40119
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 16 Jul 2021 31 Mar 2021 001-40119
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 28 May 2021 25 May 2021 001-40119
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NT 10-Q 18 May 2021 31 Mar 2021 001-40119
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 12 Mar 2021 005-92346
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 08 Mar 2021 02 Mar 2021 001-40119
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 03 Mar 2021 25 Feb 2021 001-40119
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Mar 2021 02 Mar 2021
424B4 Open 424B4 document View SEC filing for 424B4 424B4 01 Mar 2021 333-252863
EFFECT Open EFFECT document View SEC filing for EFFECT 25 Feb 2021 333-252863
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Feb 2021 25 Feb 2021
S-1MEF Open S-1MEF document View SEC filing for S-1MEF S-1MEF 25 Feb 2021 333-253552
CERT Open CERT document View SEC filing for CERT NYSE CERTIFICATION 25 Feb 2021 001-40119
8-A12B Open 8-A12B document View SEC filing for 8-A12B FORM 8-A12B 25 Feb 2021 001-40119
CORRESP Open CORRESP document View SEC filing for CORRESP 24 Feb 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 24 Feb 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Feb 2021
S-1/A Open S-1/A document View SEC filing for S-1/A FORM S-1/A 22 Feb 2021 333-252863
S-1 Open S-1 document View SEC filing for S-1 FORM S-1 09 Feb 2021 333-252863
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Feb 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 31 Dec 2020
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 07 Dec 2020
DRS Open DRS document View SEC filing for DRS 07 Dec 2020 377-03858

About this filer

IBERE PHARMACEUTICALS files with the SEC under CIK 0001835205. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages